These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 7486626)
1. Neuroprotective activity of HU-211, a novel nonpsychotropic synthetic cannabinoid. Biegon A Ann N Y Acad Sci; 1995 Sep; 765():314. PubMed ID: 7486626 [No Abstract] [Full Text] [Related]
2. Anti-ischemia activity of HU-211, a non-psychotropic synthetic cannabinoid. Vered M; Bar-Joseph A; Belayev L; Berkovich Y; Biegon A Acta Neurochir Suppl (Wien); 1994; 60():335-7. PubMed ID: 7976583 [TBL] [Abstract][Full Text] [Related]
3. Ketamine promotes hippocampal CA1 pyramidal neuron loss after a short-duration ischemic insult in rats. Church J; Zeman S Neurosci Lett; 1991 Feb; 123(1):65-8. PubMed ID: 2062455 [TBL] [Abstract][Full Text] [Related]
4. Biphasic effect of taurine on excitatory amino acid-induced neurotoxicity. Tang XW; Deupree DL; Sun Y; Wu JY Adv Exp Med Biol; 1996; 403():499-505. PubMed ID: 8915388 [No Abstract] [Full Text] [Related]
5. HU-211, a nonpsychotropic cannabinoid, improves neurological signs and reduces brain damage after severe forebrain ischemia in rats. Mol Chem Neuropathol; ; . PubMed ID: 7546016 [TBL] [Abstract][Full Text] [Related]